RDS’ cover photo
RDS

RDS

Medical Equipment Manufacturing

Strasbourg, Grand Est 4,055 followers

Advancing Patient Pathways™

About us

About RDS RDS is an innovative company specializing in remote patient monitoring, developing, manufacturing and marketing MultiSense®, a next-generation remote medical monitoring solution. Headquartered in Strasbourg (France) within the IHU, RDS relies on an international team and collaborates with major research projects such as DARE and 5G-OR. Winner of several awards, including the 2020 i-Lab prize, the Grand Prix de l'Académie des Technologies 2022 and the 2023 i-Nov prize, RDS stands out for its commitment to innovation and the digital transformation of healthcare. Incubated at SEMIA/Quest for Health and accelerated by PariSanté Campus, it aims to redefine telemonitoring standards through patented technology and an eco-conscious approach. About MultiSense The MultiSense solution combines a wearable patch with a cloud-based platform and associated support services. It continuously monitors six key parameters, including heart rate, respiratory rate and oxygen saturation. The solution is protected by more than 20 patents. From the outset, sustainability has been a core focus: the device can be cleaned, refurbished and reused to minimize its carbon footprint. MultiSense is designed to support the implementation of short-stay hospitalization protocols, helping to reduce the average length of hospital stays, to ensure safer hospital discharge and to improve patients’ quality of life.

Industry
Medical Equipment Manufacturing
Company size
11-50 employees
Headquarters
Strasbourg, Grand Est
Type
Privately Held
Founded
2020
Specialties
Wearable Medical Device, Remote Patient Monitoring, Early Hospital Discharge, Predictive Medicine, Patient Pathways, e-Health, Medtech, Digital Health, HealthCare, Vital Sign Monitoring, Telemonitoring, Virtual Wards, and Transitional Care

Products

Locations

Employees at RDS

Updates

Similar pages

Browse jobs

Funding

RDS 6 total rounds

Last Round

Series A

US$ 16.4M

See more info on crunchbase